NYSE · ACN

Accenture PLC

$154.06 +$7.07 (+4.81%) 1D After hours

Key Metrics

$89.95B
Market cap
11.55×
P/E · TTM
$73.10B
Revenue · TTM
$7.79B
Net income
EPS · TTM $12.54
Dividend yield
Free cash flow $12.58B
Beta · 1Y 0.37
EBITDA · TTM $11.28B
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 30
    From its Feb 2 high, the share price fell 53%.

    Peak close $266.79 on Feb 2; trough close $124.44 on Jun 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -53%
  • Jun 18
    The stock moved -18.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 18
  • Feb 3
    The stock moved -9.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$89.95B
Enterprise value$84.09B
Shares outstanding611.9M
52-wk range$118.15 – $291.09
Avg volume · 20D3.1M
Net cash $5.86B
Book value / share$51.33
IndustryServices-Business Services, Nec
ExchangeNYSE
About Accenture PLC
IPO dateJul 19, 2001
Employees779000

Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E11.55
P/S1.23
P/FCF7.15
EV/EBITDA7.46
EV/Sales1.15
Graham №$120.33

Profitability

Gross
Operating 14.6%
Net 10.7%
FCF 17.2%
ROE / ROIC 25.9% · 29.4%

Financial Health

Current ratio1.34
Quick ratio
Debt / equity0.16
Debt / EBITDA 0.46Low leverage
Net cash $5.86B
Working capital$7.33B

Cash Flow · TTM

Operating CF $13.18B
Capex −$600.41M
Free cash flow $12.58B
Buybacks $5.67B
Dividends paid
Shareholder yield 6.3%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$120.33 vs $154.06
Trades 1.3× above classic defensive value — priced for growth
Fundamentals through 2026-05-31 · computed by TickerWolf from SEC filings